Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | GRO-a | 4005.0 | 67 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | GRO-a | 4946.0 | 70 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | GRO-a | 6692.0 | 49 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | GRO-a | 3026.0 | 59 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 1 | GRO-a | 4356.5 | 70 | ||||
N2586 | EGF | 100 | ng/mL | 1 | GRO-a | 8909.0 | 69 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | GRO-a | 9212.5 | 64 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | GRO-a | 7745.0 | 67 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | GRO-a | 9792.5 | 68 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | GRO-a | 9426.5 | 58 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | GRO-a | 6754.5 | 54 | |
N2586 | JNK-IN-11 | 0.3 | uM | 1 | GRO-a | 5785.0 | 57 | ||||
RA2159 | IGF-I | 100 | ug/mL | 1 | GRO-a | 4898.0 | 67 | ||||
RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | GRO-a | 1576.0 | 61 | |
RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | GRO-a | 2327.0 | 52 | |
RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | GRO-a | 3749.0 | 53 | |
RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | GRO-a | 3912.0 | 60 | |
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | GRO-a | 3010.0 | 53 | |
RA2159 | 1 | GRO-a | 4705.0 | 68 | |||||||
N2586 | IGF-I | 100 | ug/mL | 1 | GRO-a | 6665.0 | 63 | ||||
N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | GRO-a | 7109.0 | 66 | |
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | GRO-a | 5643.5 | 48 | |
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | GRO-a | 6076.0 | 65 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | GRO-a | 6444.0 | 38 | |
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | GRO-a | 5399.0 | 39 |